Scout | Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)

This grant supports projects using genome or epigenome editing to study genes or genetic variants related to substance use disorders. Results should be shared widely to help researchers understand the brain mechanisms involved, aiding future prevention, diagnosis, and treatment strategies.

Source

Agency: National Institutes of Health

Program: SBIR

Award

Award Ceiling: $125,000

Funding Amount: $125,000

Dates

Open for Submission: November 1, 2022

Submission Deadline: July 28, 2025

Application Window Closes: July 28, 2025

Opportunity Released: November 1, 2022

Keywords

genome editing

epigenome editing

substance use disorders

gene validation

variant characterization

genetic resources

neurobiological mechanisms

prevention strategies

diagnostic strategies

therapeutic strategies

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers